NASDAQ:SDGR Schrodinger (SDGR) Stock Price, News & Analysis $20.96 0.00 (0.00%) Closing price 07/3/2025 03:29 PM EasternExtended Trading$21.04 +0.08 (+0.38%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Schrodinger Stock (NASDAQ:SDGR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Schrodinger alerts:Sign Up Key Stats Today's Range$20.81▼$21.4250-Day Range$20.12▼$26.6952-Week Range$16.60▼$28.47Volume348,387 shsAverage Volume912,877 shsMarket Capitalization$1.54 billionP/E RatioN/ADividend YieldN/APrice Target$33.25Consensus RatingModerate Buy Company Overview Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York. Read More Schrodinger Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreSDGR MarketRank™: Schrodinger scored higher than 57% of companies evaluated by MarketBeat, and ranked 1357th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingSchrodinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSchrodinger has only been the subject of 2 research reports in the past 90 days.Read more about Schrodinger's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Schrodinger are expected to grow in the coming year, from ($2.37) to ($2.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrodinger is -7.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrodinger is -7.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSchrodinger has a P/B Ratio of 3.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Schrodinger's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.63% of the float of Schrodinger has been sold short.Short Interest Ratio / Days to CoverSchrodinger has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in Schrodinger has recently decreased by 1.96%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSchrodinger does not currently pay a dividend.Dividend GrowthSchrodinger does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted15.63% of the float of Schrodinger has been sold short.Short Interest Ratio / Days to CoverSchrodinger has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in Schrodinger has recently decreased by 1.96%, indicating that investor sentiment is improving. News and Social Media3.0 / 5News Sentiment0.42 News SentimentSchrodinger has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Schrodinger this week, compared to 4 articles on an average week.Search Interest12 people have searched for SDGR on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.MarketBeat Follows7 people have added Schrodinger to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Schrodinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $419,580.00 in company stock.Percentage Held by InsidersOnly 8.60% of the stock of Schrodinger is held by insiders.Percentage Held by Institutions79.05% of the stock of Schrodinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Schrodinger's insider trading history. Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrodinger and its competitors with MarketBeat's FREE daily newsletter. Email Address SDGR Stock News HeadlinesMS initiates coverage on AI Biotechs, flags key pipeline catalystsJuly 3 at 5:09 PM | investing.comSchrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505July 3 at 5:09 PM | msn.com379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists | True Market Insiders (Ad)Schrödinger, Inc. (SDGR) - Yahoo FinanceJuly 2 at 12:49 AM | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGRJuly 2 at 10:00 AM | prnewswire.comSchrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström MacroglobulinemiaJune 27, 2025 | tmcnet.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGRJune 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGRJune 22, 2025 | prnewswire.comSee More Headlines SDGR Stock Analysis - Frequently Asked Questions How have SDGR shares performed this year? Schrodinger's stock was trading at $19.29 at the beginning of the year. Since then, SDGR stock has increased by 8.7% and is now trading at $20.96. How were Schrodinger's earnings last quarter? Schrodinger, Inc. (NASDAQ:SDGR) issued its quarterly earnings results on Wednesday, May, 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by $0.01. The company's revenue was up 62.7% compared to the same quarter last year. Read the conference call transcript. When did Schrodinger IPO? Schrodinger (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets acted as the underwriters for the IPO. How do I buy shares of Schrodinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Schrodinger own? Based on aggregate information from My MarketBeat watchlists, some other companies that Schrodinger investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/07/2025Today7/04/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SDGR CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees790Year FoundedN/APrice Target and Rating Average Stock Price Target$33.25 High Stock Price Target$45.00 Low Stock Price Target$28.00 Potential Upside/Downside+58.6%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($2.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$187.12 million Net Margins-83.39% Pretax Margin-82.96% Return on Equity-44.74% Return on Assets-26.29% Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio3.45 Sales & Book Value Annual Sales$207.54 million Price / Sales7.41 Cash FlowN/A Price / Cash FlowN/A Book Value$5.78 per share Price / Book3.63Miscellaneous Outstanding Shares73,380,000Free Float67,067,000Market Cap$1.54 billion OptionableOptionable Beta1.58 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:SDGR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrodinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schrodinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.